BIOTECH BY THE LAKE 2020
INVESTOR SUMMIT
Thursday, May 28, 2020
9:00 – 11:45 a.m. Central Time (CST)
(7:00 – 9:45 a.m. Pacific; 8:00 – 10:45 a.m. Mountain; 10:00 – 12:45 p.m. Eastern)
BIOTECH BY THE LAKE 2020 INVESTOR SUMMIT
The second Biotech by the Lake Investor Summit (now digital), hosted by the Chemistry of Life Processes Institute at Northwestern University, Oppenheimer & Co and BioCentury, will provide an exclusive look at next-generation cancer therapies and technologies. The program will feature Northwestern’s top innovators, investment experts, and biopharma industry leaders who will discuss latest developments, hottest trends in cancer research and investment opportunities within Chicago’s growing biotech community and beyond.
Attendees
Free and open to investment bankers, asset managers, corporate investors, early-stage venture investors, global biotech industry leaders, Northwestern faculty members and select guests
PROGRAM
NORTHWESTERN FACULTY PRESENTERS
9:00 a.m. (CST) - Welcome and Introduction
Thomas V. O’Halloran, PhD
Founding Director, Chemistry of Life Processes Institute
Charles E. and Emma H. Morrison Professor of Chemistry and Professor of Molecular Biosciences, Weinberg College of Arts & Sciences; Professor of Medicine, Feinberg School of Medicine
9:05 a.m. (CST) - Protein-Like Polymers: A Peptide Therapeutic Delivery Platform Technology
Nathan Gianneschi, PhD
Jacob and Rosaline Cohn Professor of Chemistry, Departments of Chemistry, Materials Science & Engineering, Biomedical Engineering and Pharmacology, Northwestern University
9:25 a.m. (CST) - Tissue Transglutaminase/Fibronectin Interaction, a Potential New Cancer Target
Daniela Matei, MD
Diana, Princess of Wales Professor of Cancer Research; Professor of Medicine (Hematology and Oncology) and Obstetrics and Gynecology, Feinberg School of Medicine
9:45 a.m. (CST) - Design-driven Engineering of Programmable Cell-based Therapies Through Synthetic Biology
Josh Leonard, PhD
Associate Professor of Chemical and Biological Engineering; Charles Deering McCormick Professor of Teaching Excellence, Northwestern University
PANEL DISCUSSION: HOT TOPICS IN CANCER THERAPEUTICS AND TECHNOLOGIES
10:05 a.m. (CST)
Moderator:
Simone Fishburn, PhD
VP & Editor in Chief, BioCentury Inc.
Panelist:
Andrew Chan, MD, PhD
Senior Vice President of Research Biology, Genentech
Panelist:
Elizabeth McNally, MD, PhD
Director, Center for Genetic Medicine; Elizabeth J. Ward Professor of Genetic Medicine; Professor of Medicine (Cardiology) and Biochemistry and Molecular Genetics, Northwestern Feinberg School of Medicine
Panelist:
Neil Kelleher, PhD
Walter and Mary E. Glass Professor of Molecular Biosciences; Professor of Chemistry; and Professor, Biochemistry and Molecular Genetics and Medicine, Faculty Director, Northwestern Proteomics
Panelist:
Nick Saccomano, PhD
CSO-SVP, Pfizer Boulder Research and Development
CORPORATE PRESENTERS:
10:25 a.m. (CST)
Barbara Klencke, MD
Chief Development Officer, Sierra Oncology (SRRA)
10:45 a.m. (CST)
11:05 (CST)
Jonathan Zalevsky, PhD
Chief Research and Development Officer, Nektar (NKTR)
PANEL DISCUSSION: FINANCING AND INVESTING IN ONCOLOGY BIOTECH
11:25 a.m.
Moderator:
Jay Olson, CFA
Research Analyst, Oppenheimer & Co.
Panelist:
Vanessa Bhark
Senior Associate, Frazier Healthcare Partners
Panelist:
Maha Katabi, PhD, CFA
General Partner, Sofinnova Investments
Panelist:
Michael Margolis, R Ph
Managing Director, Oppenheimer & Co.
Panelist:
Alex Munns
Assistant Portfolio Manager, Driehaus Capital
11:45 a.m. - Event Concludes
(The above agenda is subject to change.)
WATCH THE VIDEO
Acknowledgement
We would like to express our gratitute to the members of the Chemistry of Life Processes Institute’s Executive Advisory Board (EAB) for their enthusiastic support for the Biotech by the Lake Investor Summit series. Our special thanks to EAB member Sujal Shah, President and CEO of CymaBay Therapeutics (CBAY), whose vision, guidance and leadership made this investor series possible.